Isis Awarded $6M CDC Grant for Development of Diagnostics for Infectious Disease | GenomeWeb

NEW YORK, Oct. 7 (GenomeWeb News) - Isis Pharmaceuticals said today it has received a three-year grant of up to $6 million from the US Centers for Disease Control and Prevention to develop an RNA-based diagnostic technology for human and animal infectious diseases as well as biodefense.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.